31 related articles for article (PubMed ID: 3323369)
1. Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance.
Williams DL; Spring L; Harris E; Roche P; Gillis TP
Antimicrob Agents Chemother; 2000 Jun; 44(6):1530-7. PubMed ID: 10817704
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.
Cambau E; Saunderson P; Matsuoka M; Cole ST; Kai M; Suffys P; Rosa PS; Williams D; Gupta UD; Lavania M; Cardona-Castro N; Miyamoto Y; Hagge D; Srikantam A; Hongseng W; Indropo A; Vissa V; Johnson RC; Cauchoix B; Pannikar VK; Cooreman EAWD; Pemmaraju VRR; Gillini L;
Clin Microbiol Infect; 2018 Dec; 24(12):1305-1310. PubMed ID: 29496597
[TBL] [Abstract][Full Text] [Related]
3. Resistance of M. leprae to quinolones: a question of relativity?
Veziris N; Chauffour A; Escolano S; Henquet S; Matsuoka M; Jarlier V; Aubry A
PLoS Negl Trop Dis; 2013 Nov; 7(11):e2559. PubMed ID: 24244784
[TBL] [Abstract][Full Text] [Related]
4. Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test.
Cambau E; Chauffour-Nevejans A; Tejmar-Kolar L; Matsuoka M; Jarlier V
PLoS Negl Trop Dis; 2012; 6(7):e1739. PubMed ID: 22860144
[TBL] [Abstract][Full Text] [Related]
5. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
[No Abstract] [Full Text] [Related]
6. [Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)].
Grosset J; Guelpa-Lauras CC; Millan J; Bodian M; Perani E
Med Trop (Mars); 1987; 47(2):171-5. PubMed ID: 3306248
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
[TBL] [Abstract][Full Text] [Related]
8. [Dynamics of establishing resistance of M. leprae to dapsone and rifampicin in Martinique].
Constant-Desportes-Relouzat M; Grosset J; Guelpalauras CC; Salvini B; Cales-Quist D
Acta Leprol; 1986; 4(3):293-300. PubMed ID: 3551468
[No Abstract] [Full Text] [Related]
9. Combined clofazimine- and dapsone-resistant leprosy. A case report.
Kar HK; Bhatia VN; Harikrishnan S
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
[TBL] [Abstract][Full Text] [Related]
10. Primary and secondary dapsone resistance of M. leprae in Martinique, Guadeloupe, New Caledonia, Tahiti, Senegal, and Paris between 1980 and 1985.
Guelpa-Lauras CC; Cartel JL; Constant-Desportes M; Millan J; Bobin P; Guidi C; Brucker G; Flageul B; Guillaume JC; Pichet C
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):672-9. PubMed ID: 3323369
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance in leprosy: lessons from past and future perspective.
Gupta UD; Katoch VM
Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
[TBL] [Abstract][Full Text] [Related]
12. Mouse foot pad technique for evaluation of drug resistance of M. leprae and other laboratory techniques to be used in leprosy control programmes.
Pattyn SR
Acta Leprol; 1983; 1(1):29-32. PubMed ID: 6401137
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]